NephroGenex
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3200 Beechleaf Ct Ste 900, Raleigh, Nort...Phone Number
(609) 986-1780Website
www.nephrogenex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NephroGenex
NephroGenex, Inc is an innovator in the development of drugs aimed at treating kidney diseases, particularly diabetic nephropathy. Their lead drug candidate, PYRIDORIN® (pyridoxamine dihydrochloride), effectively inhibits oxidative chemistries associated with the progression of diabetic nephropathy and end-stage renal disease. The company has received FDA Fast Track designation and Special Protocol Assessment for its Phase 3 Pyridorin program, highlighting its potential as a breakthrough therapy in a field with limited treatment options. NephroGenex targets patients suffering from chronic kidney disease and acute kidney injury.Explore more
NephroGenex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NephroGenex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NephroGenex is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at NephroGenex
Earning: See what the market has to say on NephroGenex recently announced quarterly report
NephroGenex, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once NephroGenex has new funding data
Product Launch: Get notified when NephroGenex launches new products
Check if NephroGenex has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if NephroGenex had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at NephroGenex
Find 3 more new buyers
Compare Similar Companies to NephroGenex
Compare insights from companies similar to NephroGenex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NephroGenex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NephroGenex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NephroGenex.
NephroGenex financials insights
Gather financial insights about NephroGenex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$37.2M
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding NephroGenex
Sign Up For FreeTo access detailed company insights
NephroGenex, Inc is an innovator in the development of drugs aimed at treating kidney diseases, particularly diabetic nephropathy. Their lead drug candidate, PYRIDORIN® (pyridoxamine dihydrochloride), effectively inhibits oxidative chemistries associated with the progression of diabetic nephropathy and end-stage renal disease. The company has recei... Read More
